Home » Business News » 2013 » October » October 9, 2013

CellaVision signs Term Sheet with potential Chinese distribution partner

October 9, 2013 - London

CellaVision has signed a Term Sheet with Mindray, with the intention to reach agreement regarding distribution of CellaVisions products, especially in China and other emerging markets.
"It is part of CellaVision's strategy to expand geographically by working with strong distribution partners with local knowledge. Collaborating with Mindray supports our focus on increasing both our market awareness, and penetration of our products in emerging markets", says Yvonne Martensson, CEO at CellaVision.
As part of the partnership evaluation, Mindray will demonstrate CellaVision's analyzers at the trade fair CCLab in Wuhan, China on October 11-13.
More information will be provided in connection with the signing of a binding agreement. The intention is to agree on the terms of a partnership before 2013 year-end. 
For more information, please contact
Yvonne Martensson, CEO, CellaVision AB
Tel: + 46 708-33 77 82 | Email: 
About CellaVision
CellaVision is an innovative, global medical technology company that develops and sells its own leading systems for routine analysis of blood and other body fluids in health care services. The products rationalize manual laboratory work, and secure and support effective workflows and skills development within and between hospitals. The company has leading- edge expertise in image analysis, artificial intelligence and automated microscopy. In most countries sales are via global partners. Products are sold directly in the Nordic countries and via subsidiaries in the US, Canada and Japan. CellaVision's registered office is in Lund, Sweden. The share is listed on the Nasdaq OMX Stockholm, Small Cap list. Read more at 

About Mindray
Mindray is a leading developer, manufacturer and marketer of medical devices worldwide. Mindray maintains its global headquarters in Shenzhen, China, U.S. headquarters in Mahwah, New Jersey and multiple sales offices in major international markets. From its main manufacturing and engineering base in China, Mindray supplies through its worldwide distribution network a broad range of products across three primary business segments, namely patient monitoring and life support, in-vitro diagnostic, and medical imaging systems. For more information, please visit

This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients.

The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the
information contained therein.

Source: CellaVision AB via Thomson Reuters ONE



Comment on this story